Φορτώνει......
Randomized, Placebo-controlled Crossover Study of Dalfampridine Extended-release in Transverse Myelitis
BACKGROUND: Dalfampridine has the potential to be effective in patients with transverse myelitis (TM) as this rare disorder shares some clinical and pathogenic similarities with multiple sclerosis. METHODS: This is a randomized, double-blind, placebo-controlled crossover study of dalfampridine exten...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Mult Scler J Exp Transl Clin |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
SAGE Publications
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5731631/ https://ncbi.nlm.nih.gov/pubmed/29270309 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217317740145 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|